InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc.

HRMY Clue Score72
United States Fiscal year ends December CIK 0001802665
$40.28 +1.72% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $40.28 +14.01% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 19 Aug 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue6.0Operating income−145.9Net income−152.0EPS, diluted−24.07Fiscal year 2020Revenue159.7 +2,564.6%Operating income17.0Net income−36.9EPS, diluted−2.48Fiscal year 2021Revenue305.4 +91.2%Operating income87.5Net income34.6EPS, diluted0.58Fiscal year 2022Revenue437.9 +43.4%Operating income120.2Net income181.5 +424.5%EPS, diluted2.97Fiscal year 2023Revenue582.0 +32.9%Operating income192.0Net income128.9 −29.0%EPS, diluted2.13Fiscal year 2024Revenue714.7 +22.8%Operating income190.8Net income145.5 +12.9%EPS, diluted2.51Fiscal year 2025Revenue868.5 +21.5%Operating income208.5Net income158.7 +9.1%EPS, diluted2.71
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 6.0 159.7 305.4 437.9 582.0 714.7 868.5
Growth +2,564.6% +91.2% +43.4% +32.9% +22.8% +21.5%
Operating income −145.9 17.0 87.5 120.2 192.0 190.8 208.5
Net income −152.0 −36.9 34.6 181.5 128.9 145.5 158.7
Growth +424.5% −29.0% +12.9% +9.1%
EPS, diluted −24.07 −2.48 0.58 2.97 2.13 2.51 2.71

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin73.7%Operating margin−2,433.8%Net margin−2,535.1%Free cash flow margin−1,260.8%Fiscal year 2020Gross margin82.6%Operating margin10.6%Net margin−23.1%Free cash flow margin−1.9%Fiscal year 2021Gross margin81.8%Operating margin28.7%Net margin11.3%Free cash flow margin32.2%Fiscal year 2022Gross margin80.9%Operating margin27.4%Net margin41.4%Free cash flow margin33.0%Fiscal year 2023Gross margin79.2%Operating margin33.0%Net margin22.1%Free cash flow margin37.6%Fiscal year 2024Gross margin78.1%Operating margin26.7%Net margin20.4%Free cash flow margin30.6%Fiscal year 2025Gross margin77.2%Operating margin24.0%Net margin18.3%Free cash flow margin40.1%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 73.7% 82.6% 81.8% 80.9% 79.2% 78.1% 77.2%
Operating margin −2,433.8% 10.6% 28.7% 27.4% 33.0% 26.7% 24.0%
Net margin −2,535.1% −23.1% 11.3% 41.4% 22.1% 20.4% 18.3%
Free cash flow margin −1,260.8% −1.9% 32.2% 33.0% 37.6% 30.6% 40.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−75.4Capital expenditure−0.1Free cash flow−75.6Fiscal year 2020Operating cash flow−3.0Capital expenditure−0.0Free cash flow−3.0Buybacks−0.2Fiscal year 2021Operating cash flow98.6Capital expenditure−0.3Free cash flow98.3Fiscal year 2022Operating cash flow144.5Capital expenditure−0.2Free cash flow144.3 +46.9%Fiscal year 2023Operating cash flow219.4Capital expenditure−0.3Free cash flow219.1 +51.8%Buybacks−100.0Fiscal year 2024Operating cash flow219.8Capital expenditure−1.2Free cash flow218.7 −0.2%Fiscal year 2025Operating cash flow348.2Capital expenditure−0.3Free cash flow347.9 +59.1%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −75.4 −3.0 98.6 144.5 219.4 219.8 348.2
Capital expenditure −0.1 −0.0 −0.3 −0.2 −0.3 −1.2 −0.3
Free cash flow −75.6 −3.0 98.3 144.3 219.1 218.7 347.9
Growth +46.9% +51.8% −0.2% +59.1%
Buybacks n/a −0.2 n/a n/a −100.0 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash24.5Total debt97.9Net cash (debt)−73.5Shareholders’ equity−422.9Fiscal year 2020Cash228.6Total debt194.3Net cash (debt)34.4Shareholders’ equity97.2Debt to equity2.00Fiscal year 2021Cash234.3Total debt192.0Net cash (debt)42.3Shareholders’ equity186.5Debt to equity1.03Fiscal year 2022Cash243.8Total debt191.6Net cash (debt)52.1Shareholders’ equity402.8Debt to equity0.48Fiscal year 2023Cash311.7Total debt193.6Net cash (debt)118.1Shareholders’ equity467.0Debt to equity0.41Fiscal year 2024Cash453.0Total debt179.3Net cash (debt)273.7Shareholders’ equity659.2Debt to equity0.27Fiscal year 2025Cash752.5Total debt163.7Net cash (debt)588.8Shareholders’ equity870.2Debt to equity0.19
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 24.5 228.6 234.3 243.8 311.7 453.0 752.5
Total debt 97.9 194.3 192.0 191.6 193.6 179.3 163.7
Net cash (debt) −73.5 34.4 42.3 52.1 118.1 273.7 588.8
Shareholders’ equity −422.9 97.2 186.5 402.8 467.0 659.2 870.2
Debt to equity n/a 2.00 1.03 0.48 0.41 0.27 0.19

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
6.0 159.7 305.4 437.9 582.0 714.7 868.5
Growth +2,564.6% +91.2% +43.4% +32.9% +22.8% +21.5%
1.6 27.7 55.5 83.5 121.2 156.8 198.3
4.4 132.0 249.9 354.4 460.8 557.9 670.1
Growth +2,887.9% +89.3% +41.8% +30.0% +21.1% +20.1%
69.6 19.4 30.4 70.9 76.1 145.8 189.6
36.4 39.7 63.9 84.0 95.3 110.4 152.5
−145.9 17.0 87.5 120.2 192.0 190.8 208.5
Growth +415.3% +37.3% +59.8% −0.6% +9.2%
−152.0 −36.9 37.4 104.7 173.4 191.8 215.1
n/a n/a 2.8 −76.8 44.5 46.3 56.4
−152.0 −36.9 34.6 181.5 128.9 145.5 158.7
Growth +424.5% −29.0% +12.9% +9.1%
Per share
−24.07 −2.48 0.60 3.07 2.17 2.56 2.76
−24.07 −2.48 0.58 2.97 2.13 2.51 2.71
Growth +412.1% −28.3% +17.8% +8.0%
7.8 25.8 57.5 59.2 59.5 56.9 57.5
7.8 25.8 59.2 61.1 60.4 57.9 58.5
Growth +231.4% +129.7% +3.2% −1.2% −4.1% +1.2%

† The diluted share count jumps at 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 40.3% a year over five years.
  • Operating margin is up 13.4 points on five years ago, at 24.0%.
  • A net loss in 2 of 7 years on file.